WebApr 11, 2024 · Ms. Wellman succeeds Sheryl Telford, the company’s first Chief Sustainability Officer, who retired at the end of March. Ms. Wellman will lead Chemours’ continued effort to achieve its Corporate Responsibility Commitment goals, including at least a 99% reduction in fluorinated organic compound emissions, achieving net zero … Web14 hours ago · The Aluminium Cleaner Market Report presents a comprehensive analysis of the leading competitors in the market, incorporating historical data, SWOT analysis, and the latest global developments ...
CC - Chemours Company Stock Competitors - Barchart.com
WebApr 12, 2024 · 10 Wall Street analysts have issued twelve-month target prices for Chemours' stock. Their CC share price forecasts range from $27.00 to $43.00. On average, they predict the company's stock price to reach $36.33 in the next year. This suggests a possible upside of 27.5% from the stock's current price. View analysts price targets for … WebChemours Profile and History. Founded in 2015, Chemours manufactures and produces agricultural chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, … constrictive prostatitis
Home Chemours
WebMar 20, 2024 · Future Competition: Chemours's Fastest Growing Competitors These companies are in the same general field as Chemours and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years. WebDiscover information and data insights on Chemours Co's key competitors and market peers. Competitor comparison Honeywell International Inc Headquarters United States of America No. of employees 99,000 Revenue $35.5B Entity type Public AGC Inc Headquarters Japan No. of employees 55,999 Revenue $18.1B Entity type Public … WebApr 12, 2024 · According to the issued ratings of 10 analysts in the last year, the consensus rating for Chemours stock is Hold based on the current 1 sell rating, 6 hold ratings and 3 buy ratings for CC. The average twelve-month price prediction for Chemours is $36.33 with a high price target of $43.00 and a low price target of $27.00. constrictive pyramid population